ATE463511T1 - Verwendung von cardiotrophin zur modulation der stammzellenproliferation - Google Patents

Verwendung von cardiotrophin zur modulation der stammzellenproliferation

Info

Publication number
ATE463511T1
ATE463511T1 AT04737879T AT04737879T ATE463511T1 AT E463511 T1 ATE463511 T1 AT E463511T1 AT 04737879 T AT04737879 T AT 04737879T AT 04737879 T AT04737879 T AT 04737879T AT E463511 T1 ATE463511 T1 AT E463511T1
Authority
AT
Austria
Prior art keywords
cell proliferation
stem cell
methods
cardiotrophin
cells
Prior art date
Application number
AT04737879T
Other languages
English (en)
Inventor
Lynn Megeney
Original Assignee
Ottawa Hospital Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ottawa Hospital Res Inst filed Critical Ottawa Hospital Res Inst
Application granted granted Critical
Publication of ATE463511T1 publication Critical patent/ATE463511T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657—Cardiomyocytes; Heart cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AT04737879T 2003-06-25 2004-06-25 Verwendung von cardiotrophin zur modulation der stammzellenproliferation ATE463511T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48200103P 2003-06-25 2003-06-25
PCT/CA2004/000940 WO2004113380A1 (en) 2003-06-25 2004-06-25 Use of cardiotrophin to modulate stem cell proliferation

Publications (1)

Publication Number Publication Date
ATE463511T1 true ATE463511T1 (de) 2010-04-15

Family

ID=33539330

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04737879T ATE463511T1 (de) 2003-06-25 2004-06-25 Verwendung von cardiotrophin zur modulation der stammzellenproliferation

Country Status (11)

Country Link
US (2) US20060115464A1 (de)
EP (1) EP1639003B1 (de)
JP (1) JP4838710B2 (de)
CN (1) CN1812996A (de)
AT (1) ATE463511T1 (de)
AU (1) AU2004249340B2 (de)
CA (1) CA2570464A1 (de)
DE (1) DE602004026445D1 (de)
ES (1) ES2344204T3 (de)
NZ (1) NZ544828A (de)
WO (1) WO2004113380A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7862810B2 (en) * 2000-07-31 2011-01-04 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
US20050129616A1 (en) * 2001-05-25 2005-06-16 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to TRAIL receptors
US20050261189A1 (en) * 2004-04-16 2005-11-24 Hydra Biosciences, Inc. Methods of promoting cardiac cell proliferation
US8173118B2 (en) 2004-07-30 2012-05-08 Mayo Foundation For Medical Education And Research Compositions consisting essentially of TGF-β, BMP-2 FGF-4, leukemia inhibitory factor, IGF-1, IL-6 and H-α-thrombin
CA2612394C (en) * 2005-06-15 2017-02-21 The Ohio State University Research Foundation Her-2 peptides
US9765298B2 (en) 2006-07-24 2017-09-19 Mayo Foundation For Medical Education And Research Methods and materials for providing cardiac cells
US20090042795A1 (en) * 2007-06-05 2009-02-12 Pasan Fernando Cardiac stem cell proliferation proteins, fragments thereof and methods of modulating stem cell proliferation and differentiation
WO2009145761A1 (en) 2008-05-27 2009-12-03 Mayo Foundation For Medical Education And Research Methods and materials for using cells to treat heart tissue
US8193161B2 (en) 2008-06-09 2012-06-05 New York Medical College Compositions comprising cardiac stem cells overexpressing specific micrornas and methods of their use in repairing damaged myocardium
US20100234283A1 (en) 2009-02-04 2010-09-16 The Ohio State University Research Foundation Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use
EP2709653B1 (de) * 2011-04-20 2017-11-22 The U.S.A. as represented by the Secretary, Department of Health and Human Services Aav-vermittelter exendin-4-gentransfer in die speicheldrüsen zum schutz vor diabetes oder adipositas
US9962427B2 (en) 2016-07-11 2018-05-08 Ottawa Hospital Research Institute Treatment of right ventricular dysfunction due to pressure overload
CN109943533B (zh) * 2019-03-29 2021-01-01 上海交通大学医学院附属第九人民医院 一种制备脂肪干细胞外泌体的方法、脂肪干细胞外泌体及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6472585B1 (en) * 1994-04-25 2002-10-29 Genentech, Inc. Cardiotrophin-1 defective mouse
US5534615A (en) * 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
WO1995029237A1 (en) * 1994-04-25 1995-11-02 Genentech, Inc. Cardiotrophin and uses therefor
US20040006018A1 (en) * 1996-02-14 2004-01-08 Genentech, Inc. Cardiotrophin and uses therefor
US5851984A (en) * 1996-08-16 1998-12-22 Genentech, Inc. Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
WO1998044142A1 (en) * 1997-04-01 1998-10-08 The General Hospital Corporation Molecular marker for muscle stem cells
US20030103951A1 (en) * 1997-07-14 2003-06-05 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
CA2296704C (en) * 1997-07-14 2010-10-19 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
US20020142457A1 (en) * 1999-12-28 2002-10-03 Akihiro Umezawa Cell having the potentiality of differentiation into cardiomyocytes
US7547674B2 (en) * 2001-06-06 2009-06-16 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
US20030027330A1 (en) * 2001-04-02 2003-02-06 Robert Lanza Method for facilitating the production of differentiated cell types and tissues from embryonic and adult pluripotent and multipotent cells
ES2200646B1 (es) * 2001-09-21 2005-05-01 Fundacion Para La Investigacion Medica Aplicada Uso de la cardiotrofina en enfermedades hepaticas.
WO2010118059A1 (en) * 2009-04-06 2010-10-14 Capricor, Inc. Systems and methods for cardiac tissue repair

Also Published As

Publication number Publication date
DE602004026445D1 (de) 2010-05-20
CN1812996A (zh) 2006-08-02
US20060115464A1 (en) 2006-06-01
CA2570464A1 (en) 2004-12-29
JP2007537692A (ja) 2007-12-27
ES2344204T3 (es) 2010-08-20
AU2004249340A1 (en) 2004-12-29
US20160222352A1 (en) 2016-08-04
EP1639003B1 (de) 2010-04-07
AU2004249340B2 (en) 2011-04-21
JP4838710B2 (ja) 2011-12-14
NZ544828A (en) 2008-10-31
EP1639003A1 (de) 2006-03-29
WO2004113380A1 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
ATE463511T1 (de) Verwendung von cardiotrophin zur modulation der stammzellenproliferation
DE60238058D1 (de) Verwendung von lysyloxydase inhibitoren zur zellkultur und gewebeaufbau
GB2436737B (en) Culture medium containing kinase inhibitors,and uses thereof
ATE474052T1 (de) Verfahren zur herstellung von rekombinanten proteinen mittels inhibitoren von apoptose
WO2004113513A3 (en) Methods and compositions for modulating stem cell growth and differentiation
ATE549395T1 (de) Medium und kultur von embryonalen stammzellen
ATE517996T1 (de) Verfahren und mittel zur erhöhung der toleranz von pflanzen gegenüber stressbedingungen
ATE485065T1 (de) Gewebekonstruktionsvorrichtungen zur reparatur und regeneration von gewebe
DE602004019542D1 (de) Proteasome inhibitoren und deren verwendung
NO20001583D0 (no) Stimulering av hematopoetiske celler in vitro
MX2007001772A (es) Composiciones y metodos para auto-renovacion y diferenciacion de celulas troncales embrionicas humanas.
MX345394B (es) Modulacion de la diferenciacion de celulas madre y progenitoras, ensayos y usos de las mismas.
DK1019490T3 (da) Fremgangsmåder til modulering af hæmatopoese og vaskulær vækst
DE602004008453D1 (de) Künstliches immunorgan
CR9586A (es) Metodos para modular el desarrollo osteocondral utilizando una terapia de campo electromagnetico con impulsos
ATE382060T1 (de) Moleküle und verfahren zur inhibierung der freisetzung von kim-1
ATE480615T1 (de) Verfahren zur proliferation von stammzellen
ATE248592T1 (de) Verwendung von naaladase hemmern zur herstellung eines medikaments zur behandlung von bestimmten krankheiten
ATE542536T1 (de) 3-ä4-(dibenzoäb,füä1,4üoxazepin-11-yl)-piperazi - 1-ylü-2,2-dimethyl propansäure zur verwendung in der behandlung von schlafstörungen
ATE421574T1 (de) Zellkulturmethode zur erzeugung von prostata- ähnlichen acini
ATE445402T1 (de) Neue verwendung von pde5-hemmern
DE69624918D1 (de) Verwendung von pseudopterosin zur förderung der wundheilung
ATE478156T1 (de) Verfahren zur identifizierung von modulatoren der eoxin-bildung
DE602005021681D1 (de) Stibogluconate-natrium und il-2 zur krebsbehandlung
AR059193A1 (es) Modulacion de la actividad de mdl-1 para el tratamiento de enfermedades inflamatorias

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties